Clinical Trials Logo

Clinical Trial Summary

The PillBot System is an endoscopic capsule imaging system intended for visualization of the stomach. In contrast to currently used passive capsule endoscopy systems, and FDA cleared active magnetic system, the PillBot System uses active, motorized propulsion technology to facilitate the navigation and positioning of the capsule within the stomach anatomy for imaging of the gastric mucosa by an operator


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06212206
Study type Interventional
Source Endiatx
Contact
Status Not yet recruiting
Phase N/A
Start date May 2024
Completion date December 2024

See also
  Status Clinical Trial Phase
Completed NCT02105506 - Safety and Feasibility of TachoSil®: Application on Esophageal Anastomoses N/A
Completed NCT03198871 - IV Acetaminophen for Post-Operative Pain Management in Enhanced Recovery After Surgery (ERAS) Population Phase 4
Not yet recruiting NCT03092414 - Linked Color Imaging Based CMV Diagnosis for Gastric Mucosal Lesions N/A
Completed NCT03776916 - Application of Simethicone in Esophagogastroscopy N/A
Not yet recruiting NCT06273319 - The Effect of Oxygen Application With Double Nasal Cannula on Respiratory Complications N/A
Not yet recruiting NCT02994472 - Gastric Emptying: in Vivo Studies in Healthy Volunteers N/A
Recruiting NCT03267355 - Indications and Outcomes of Endoscopic Ultrasound in Tanta N/A
Completed NCT01322737 - Feasibility Trial to Evaluate the Ability of the SuMO Tissue Access and Resection System N/A
Completed NCT04111393 - Transoral Removal of Specimen During Laparoscopic Gastric Resection
Recruiting NCT05249933 - Pronase Granules in Gastric Cleaning Phase 2/Phase 3
Completed NCT04479423 - The Usage of Soda-Water in Gastric Preparation for Magnetically Controlled Capsule Endoscopy N/A
Completed NCT05392452 - Fully Closed-Loop Insulin Delivery in Abdominal Surgery (CLAB) N/A
Not yet recruiting NCT05801055 - A Study to Evaluate Endoscopic Visibility of Stomach After a Combination Drink of N-acetylcysteine and Simethicone Phase 3